Most Read Articles
Pearl Toh, 15 May 2018
Biologic therapy for treating psoriasis, in particular anti-TNF agents, can also help reduce coronary plaque besides suppressing inflammation in the skin, suggests a study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions in San Diego, California, US.
Tristan Manalac, 10 Mar 2018
Cost of treatment is a major driver of patients’ primary nonadherence to acne medication, according to a recent study. Physicians who openly discuss medications costs and provide a plan of action in case patients are unable to fill prescriptions may improve treatment adherence.
01 Aug 2015
A higher dose of amikacin enhanced the rates of pharamacodynamic target attainment in simulations of paediatric patients with burn wound sepsis, based on a study.
31 Jan 2018
Oral tranexamic acid (TA) may help improve moderate-to-severe melasma with negligible side effects, according to a recent study.

Acne scarring: A shift from treatment to prevention

09 Dec 2016
All patients with acne are potentially at risk of scarring. Professor Goh Chee Leok addresses this issue by focussing on preventing the development of scars in his talk at the 41st Annual Meeting of the Dermatological Society of Malaysia held in Kuching, Sarawak.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
Pearl Toh, 15 May 2018
Biologic therapy for treating psoriasis, in particular anti-TNF agents, can also help reduce coronary plaque besides suppressing inflammation in the skin, suggests a study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions in San Diego, California, US.
Tristan Manalac, 10 Mar 2018
Cost of treatment is a major driver of patients’ primary nonadherence to acne medication, according to a recent study. Physicians who openly discuss medications costs and provide a plan of action in case patients are unable to fill prescriptions may improve treatment adherence.
01 Aug 2015
A higher dose of amikacin enhanced the rates of pharamacodynamic target attainment in simulations of paediatric patients with burn wound sepsis, based on a study.
31 Jan 2018
Oral tranexamic acid (TA) may help improve moderate-to-severe melasma with negligible side effects, according to a recent study.